Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by Levonorgestrelreleasing Intrauterine System

Research Leaders

9 sponsors active, led by Society of Family Planning

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
Phase 3 (1)
Phase 4 (2)

Trial Status

Completed5
Unknown1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06816901Phase 4CompletedPrimary

Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study

NCT06766409Not ApplicableNot Yet RecruitingPrimary

Effect of Joint Provision of Community Group-based Counseling with Individual Counseling on Postpartum Contraception

NCT06766396Not ApplicableCompletedPrimary

Predictors of PPIUCD Discontinuation at Two Years: A Clinical Study in Pakistan

NCT05756998Not ApplicableUnknownPrimary

New Method of IUD Insertion During Cesarian Section

NCT02866279Not ApplicableCompleted

Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial

NCT02866643Phase 3CompletedPrimary

Labor and Delivery Implant Insertion: A Randomized Controlled Trial

NCT01555931Phase 4CompletedPrimary

Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding

Showing all 7 trials

Research Network

Common Treatments

  • Levonorgestrelreleasing Intrauterine System1
  • Cesarian Section1
  • Postpartum Intrauterine Contraceptive Device Ppiucd1
  • Etonogestrelimmediate1
  • Medroxyprogesterone Acetate1

Active Sponsors

  • Society of Family Planning2
  • Cairo University1
  • Montefiore Medical Center1
  • Stanford University1
  • Center for Research on Environment, Health and Population Activities1

Top Investigators

Related Conditions

  • Family Planning2
  • Dmpa1
  • Lactation1
  • Contraception1
  • Reproductive Health1

Activity Timeline